Long-term treatment with the EGb761 Ginkgo biloba extract significantly lowered the APP protein levels in a transgenic AD mouse model, suggesting that the potential neuroprotective properties of EGb761 may be, at least in part, related to its APP lowering activity69. This evidence concerns the gene APP and Alzheimer disease.